News
13d
GlobalData on MSNBiomX doses first subject in Phase IIb trial of cystic fibrosis treatmentBiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...
A drug once intended to treat diabetes, Halicin, is showing new promise as a potent weapon against multidrug-resistant (MDR) ...
Most of these microbes are harmless – some even helpful – but under the right conditions, a few can make you seriously ill ...
From your phone to your toothbrush, invisible armies of bacteria are lurking on the everyday objects you touch the most. Here ...
On hot summer days, few things are more refreshing than a dip in the pool. But have you ever wondered if the pool is as clean ...
An immunologist and infectious disease specialist has revealed the unique set of risks at public pools and water parks ...
The Conversation on MSN5d
How germy is the public pool? An infectious disease expert weighs in on poop, pee and perspiration – and the deceptive smell of chlorineMost pool-related illnesses won’t kill you, but no one wants to spend their vacation or a week of beautiful summer days in ...
EXCLUSIVE: In the summer we end up wearing our smartwatches all day and night. But swab tests from 7 in 10 of them reveal a ...
BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results